Fitoestrogeni

1
Fitoestrogeni
2
(No Transcript)
3
(No Transcript)
4
ER in cell cycle progression
Myc
ER
Cdc25A
CyclinE Cdk2
CyclinD1 Cdk4
E2F
Rb
DNA pol a Cyclins E,A B-Myb
G1
S
5
Estrogen Receptor
6
Estrogen Receptors
http//www.bio.cmu.edu/Courses/BiochemMols/ER/ERc
hime
7
Estrogen Receptors

• ER-a
• Uterus, testis, pituitary, ovary, epididymis, and
  adrenal gland.
• ER-b (Kuiper et al. 1996)
• brain, kidney, prostrate, ovary, lung, bladder,
  intestine, and epididymis.
• 88 identity with rat ER-b 47 identity with
  human ER-a
• Membrane localized ER (Pietras and Szego, 1997)
• ERa and b differ in C-terminal ligand binding
  domains and N-terminal transactivation domains.
  Highest homology in DNA binding domain.

8
Estradiol
Growth factors
MAPK
P
P
P
P
P
DBD
AF-2
AF-1
AH
9
Regulation of ER activity by coactivators and
corepressors
10
(No Transcript)
11
Estrogen Signaling
Hall et al. 2001. J. Biol. Chem., 276 36869-36872
12
ER effects on different cell types
13
Estrogen has multiple effects
14
Antiestrogens can stop harmful effects of estrogen
15
Ligand Induces a Conformational Change in the
LBD that Repositions helix 12
No Ligand
Agonist
16
NR Antagonists Alter the Position of Helix 12
Agonist (ER)
Antagonist (ER)
No Ligand
17
SERMs
(Selective Estrogen Receptor Modulators)
18
Phytoestrogens
Aherne and OBrien, 2002. Nutrition 1875-81.
19
Phytoestrogens
Benassayag, et al., 2002. J. Chromatogr.B
777233-248.
20
Comparison of binding affinities and
transactivation of estrogen and phytoestrogens
Belcher Zsarnovszky, 2001. J. Pharmacol. Exp.
Therap. 299408-414
21
Dietary Sources of Phytoestrogens
22
Pytoestrogens in humans

• Fitoestrogeni hanno una attivita piu debole di
  quella degli estrogeni circolanti (17-b-estradiol
  or estrone).
• Fitoestrogeni possono legarsi alla sex steroid
  binding protein (SBP) e a-feroprotein (AFP) e
  circolare.
• Fitoestrogeni sono coniugati nel fegato (da
  sulfotransferasi and UDP-glucoronyosyl
  transferasi), circolano nel plasma ed escreti
  nelle urine.
• Livelli di Fitoestrogeni sono piu alti nei
  fluidi dei dotti prostatici e mammari di quelli
  del plasma.
• Le urine dei vegetariani possono contenere 1000
  volte piu Fitoestrogeni che estrogeni totali.
• Fitoestrogeni hanno effetti inibitori a 0.5-50mM
  che sono livelli simili alle urine.

23
Fitoestrogeni (PEs) della Soia

• Genistein, daidzein, coumesterol, and equol si
  legano e transattivano ER a and b (0.1-10mM)
• Genistetin ha una affinita piu alta per ERb.
• Soia PEs influenzano la progressione del ciclo
  cellulare, crescita e differenziamento. Hanno
  attivita antiossidanti.

24
Red wine phytoestrogensResveratrol, quercetin,
and anthocyanins

• Antioxidant, anti-apoptosis,
  anti-inflammatory, anti-cancer, and
  anti-invasive.
• Reduces Cu-induced LDL oxidation by binding to
  LDL via a glycosidic ether bond. Increases HDL
  cholesterol. Inhibits platelet activation.
• Ameliorates neuronal damage due to ethanol
  consumption. Probably via antioxidant effect.
  Minimizes effects of NOS activity by ehtanol.
  Inhibits ethanol-induced arachidonic acid release
  and cycloxygenase activity.
• Anti-ageing role?
• inhibitory effects on cancer initiation,
  growth promotion progression and angiogenesis in
  model systems.
• The anti-proliferative activity of resveratrol
  is mediated by p38-MAPKs via p53 mediated
  inhibition. Resveratrol may inhibit apoptosis
  induced by oxidized lipoproteins through
  inhibition of NF-kB and AP-1 pathways.
• Resveratrol inhibits protein kinase C, Akt,
  and FAK activities in ER a () breast cancer
  cells.

25
Genistein
Genistein  446-72-0
Genistein  446-72-0
Genistein  446-72-0
Synonyms 4',5,7-Trihydroxyisoflavone
Synonyms 4',5,7-Trihydroxyisoflavone
Synonyms 4',5,7-Trihydroxyisoflavone
4',5,7-Trihydroxyisoflavone

• Both estrogenic and anti-estrogenic effects
• Inhibitor of tyrosine kinases
• 20-fold higher binding affinity for ER-b than
  ER-a (Makela et al. 1999)

26
Phytoestrogens in Human Health

• Cancer preventive
• Post-menopausal supplement
• Prevention of osteoporosis
• Cardiovascular health
• Fertility
• Breast enhancement

References Kurzer, 2003. J. Nutr. 133
1983S-1986S. Benassayag, et al., 2002. J.
Chromatogr.B 777233-248.
27
Cancer preventive

• Benefits to human breast and uterine cancer
  controversial.
• Genistein can be carcinogenic in uterine cancer
  at neonatal exposure.
• Cancer protective in animal studies, especially
  when exposed during breast development.
• Isoflavonoids and lignans stimulate proliferation
  of ER breast cancer cells.
• Inhibit cell growth at high concentrations and in
  ERa (-) breast cancer cells.
• Therefore, ER b may have cancer protective
  effect.
• Anti-angiogenic effects of genistein, daidzein,
  and biochanin A may contribute to antitumor
  activity.
• Anti-oxidants in vitro and in vivo.

28
Post-menopausal therapy

• In 2002, the Womens Health Initiative (WHI)
  trial of estrogen/progestin therapy was halted
  midtrial due to high incidence of breast cancer
  and cardiovascular disease.
• Consumption of 30mg/d soy isoflavones may reduce
  hot flashes by 30-50.

29
Prevention of osteoporosis

• Isoflavone intake increases bone mineral density.
• Can be useful in preventing post-menopausal
  osteoporosis.
• Diets rich in phytoestrogens can protect
  long-term bone loss (Setchell Lydeking-Olsen,
  2003. Am. J. Clin. Nutr. 78593S-609S) .

30
Cardiovascular health

• Average intake of 47g/day soy protein results in
  9 decrease in total cholesterol,13 decrease in
  LDL cholesterol, and a trend towards HDL
  cholesterol.
• Flavanoids decrease platelet aggregation.
• Genistein-induced inhibition of growth factor
  activity can interfere with platelet and thrombin
  action.

31
Effects on fertility (premenopausal)

• Interferes with menstrual cycle (delay)
• Reduced LH and FSH and progesterone.
• Male rodents exposed to PEs in early life
  impaired semen quality, congenital malformations,
  testicular cancer
• (coumesterol, delay in mating)